DAVITA INC. Purchase Obligation, to be Paid, Year Five
DAVITA INC. (DVA) had Purchase Obligation, to be Paid, Year Five of $445.94 million as of 2025-12-31, per its 10-K filed 2026-02-11.
Financial Statements › Notes › Commitment and Contingencies › Purchase Obligation, Fiscal Year Maturity › Purchase Obligation, to be Paid, Year Four and Five
us-gaap:PurchaseObligationDueInFifthYear · last filed 2026-02-11
- 2025-12-31: Purchase Obligation, to be Paid, Year Five $445.94M.
- 2024-12-31: Purchase Obligation, to be Paid, Year Five $414.49M.
- 2023-12-31: Purchase Obligation, to be Paid, Year Five $178.56M.
| Period end | Purchase Obligation, to be Paid, Year Five |
|---|---|
| 2025-12-31 | $445.94M 10-K · filed 2026-02-11 |
| 2024-12-31 | $414.49M 10-K · filed 2025-02-13 |
| 2023-12-31 | $178.56M 10-K · filed 2024-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |